trv734
Small moleculeexperimental
Clinical trial activity
3 trials · 2 clinical orgs · 0 marketing orgs
Phase 1
2
Phase 2
1
Phase 3
0
Phase 4
0
Earliest trial started Jul 1, 2014 (NCT02211625)
Timeline
Indications
Mechanism of action
- Mu-opioid receptorAGONIST
Q8CGM4 agonist
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- trv734
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT04316559 | Phase 2 | Apr 23, 2020 | National Institute on Drug Abuse (NIDA) |
| NCT02411500 | Phase 1 | Feb 1, 2015 | Trevena Inc. |
| NCT02211625 | Phase 1 | Jul 1, 2014 | Trevena Inc. |
Showing 3 of 3 trials
Page 1 / 1
Organizations
Research & Development (2)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Trevena Inc. | For profit | 2 | 2 | 1 | 2014 |
| National Institute on Drug Abuse (NIDA) | Government | 1 | 1 | 1 | 2020 |
2 organizations
Page 1 / 1